Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.9
5.2
Journals
Vaccines
Special Issues
Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant...
share announcement

Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant Women, Healthcare Workers and Patients with Chronic Diseases—Second Edition

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".

Deadline for manuscript submissions: closed (15 September 2024) | Viewed by 4223

Special Issue Editors

Dr. Cristina Genovese

E-Mail Website
Guest Editor
Department of Biomedical Sciences and Morphological and Functional Images (BIOMORF), University of Messina, 98124 Messina, Italy
Interests: communicable diseases and vaccination strategies; risk communication; non-communicable disease; public health; HCAIs
Special Issues, Collections and Topics in MDPI journals
Dr. Squeri Raffaele

E-Mail Website
Guest Editor
Department of Biomedical Sciences, Dental Sciences and Morpho-Functional Images, University of Messina, 98125 Messina, Italy
Interests: vaccination coverage; vaccination strategies; healthcare-associated infections; hospital hygiene; flu
Special Issues, Collections and Topics in MDPI journals
Dr. Claudio Costantino

E-Mail Website
Guest Editor
1. Department of Health Promotion, Maternal and Child Care, Internal Medicine and Excellence Specialties, University of Palermo, 90127 Palermo, Italy
2. Vaccination Unit, University Hospital of Palermo, Palermo, Italy
Interests: vaccination; vaccines; vaccine hesitancy; vaccine outreach; vaccine communication; paediatric vaccination; adolescent vaccination; adult vaccination; elderly vaccination
Special Issues, Collections and Topics in MDPI journals
Dr. Anna Odone

E-Mail Website
Guest Editor
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, PV, Italy
Interests: public health; epidemiology; prevention; vaccines; immunisation policies; information and communication technology, digital health
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, a phenomenon known as "vaccine hesitancy" has spread throughout the world, even among healthcare workers, determining a reduction in vaccination coverage, although vaccination is widely considered to be an efficacious and cost-effective health technology.

Although some data about vaccination coverage are not systematically available for some at-risk categories, i.e., pregnant women, healthcare workers, and patients with chronic diseases, the international literature shows a poor adhesion.

Manuscripts reporting on vaccines administered to pregnant women, at-risk patients (with chronic diseases such as, i.e., HIV or kidney failure, or other risk factors), and healthcare workers and on strategies adopted to promote vaccination adherence by these categories are welcomed for this Special Issue.

This Special Issue encourages the submission of original articles, systematic reviews, meta-analyses, short communications, and other types of articles that describe measures and strategies to improve vaccination coverage in these categories that could be adapted in other settings and countries.

Dr. Cristina Genovese
Dr. Squeri Raffaele
Dr. Claudio Costantino
Dr. Anna Odone
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccination coverage
  • improvement
  • at-risk populations
  • pregnancy
  • healthcare workers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

10 pages, 251 KiB  
Article
Vaccination and Trust in the National Health System among HIV+ Patients: An Italian Cross-Sectional Survey
by Fabrizio Bert, Antonino Russotto, Alex Pivi, Benedetta Mollero, Gianluca Voglino, Giancarlo Orofino and Roberta Siliquini
Vaccines 2023, 11(8), 1315; https://doi.org/10.3390/vaccines11081315 - 2 Aug 2023
Viewed by 1303
Abstract
Background: This study aimed to evaluate the knowledge, attitudes, and practises (KAP) of individuals living with HIV (PLWH) regarding vaccines and their trust in the Italian national health system (NHS). Methods: A cross-sectional survey was conducted at Amedeo di Savoia Hospital in Turin, [...] Read more.
Background: This study aimed to evaluate the knowledge, attitudes, and practises (KAP) of individuals living with HIV (PLWH) regarding vaccines and their trust in the Italian national health system (NHS). Methods: A cross-sectional survey was conducted at Amedeo di Savoia Hospital in Turin, Italy, involving 160 HIV-positive patients. Descriptive statistics were utilised to analyse variables such as vaccination status and intention, perceived risk of infection, and disease severity. The infections were categorised into sexually transmitted diseases and other vaccine-preventable diseases. Results: Except for the perceived severity of infection, there were no significant differences in the percentages between the two infection groups for the variables examined. Concerning patients’ perception of the Italian NHS, a high percentage of the sample believed in the information provided by healthcare workers (HCWs) (95.6%) and considered HCWs up-to-date on vaccines (93.1%). However, a considerable proportion expressed concerns about insufficient information on vaccine risks from HCWs (33.3%), perceived judgement by HCWs for vaccine refusal (40.3%), and suspected financial interests of HCWs in vaccination (19.5%). Conclusions: Some HIV+ patients may hesitate to be vaccinated or hold misconceptions about the severity of certain infectious diseases. Additionally, there are concerns about trust in the Italian NHS and communication by HCWs. Full article
(This article belongs to the Special Issue Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant Women, Healthcare Workers and Patients with Chronic Diseases—Second Edition)
10 pages, 277 KiB  
Article
Safety of Rotavirus Vaccination in Preterm Infants Admitted in Neonatal Intensive Care Units in Sicily, Italy: A Multicenter Observational Study
by Claudio Costantino, Arianna Conforto, Nicole Bonaccorso, Livia Cimino, Martina Sciortino, Mario Palermo, Kim Maiolo, Lucia Gabriella Tina, Pasqua Maria Betta, Mariacarmela Caracciolo, Carmine Mattia Loretta, Alessandro Arco, Eloisa Gitto, Salvino Marcello Vitaliti, Domenica Mancuso, Giuliana Vitaliti, Vincenzo Rosella, Giuseppa Pinello, Giovanni Corsello, Gregorio Serra, Bruna Gabriele, Fabio Tramuto, Vincenzo Restivo, Emanuele Amodio and Francesco Vitaleadd Show full author list remove Hide full author list
Vaccines 2023, 11(4), 718; https://doi.org/10.3390/vaccines11040718 - 23 Mar 2023
Cited by 5 | Viewed by 2057
Abstract
Rotavirus (RV) is among the most common vaccine-preventable diseases in children under five years of age. Despite the severity of rotavirus pathology in early childhood, rotavirus vaccination for children admitted to the neonatal intensive care unit (NICU), who are often born preterm and [...] Read more.
Rotavirus (RV) is among the most common vaccine-preventable diseases in children under five years of age. Despite the severity of rotavirus pathology in early childhood, rotavirus vaccination for children admitted to the neonatal intensive care unit (NICU), who are often born preterm and with various previous illnesses, is not performed. This multicenter, 3-year project aims to evaluate the safety of RV vaccine administration within the six main neonatal intensive care units of the Sicilian Region to preterm infants. Methods: Monovalent live attenuated anti-RV vaccination (RV1) was administered from April 2018 to December 2019 to preterm infants with gestational age ≥ 28 weeks. Vaccine administrations were performed in both inpatient and outpatient hospital settings as a post-discharge follow-up (NICU setting) starting at 6 weeks of age according to the official immunization schedule. Any adverse events (expected, unexpected, and serious) were monitored from vaccine administration up to 14 days (first assessment) and 28 days (second assessment) after each of the two scheduled vaccine doses. Results: At the end of December 2019, 449 preterm infants were vaccinated with both doses of rotavirus vaccine within the six participating Sicilian NICUs. Mean gestational age in weeks was 33.1 (±3.8 SD) and the first dose of RV vaccine was administered at 55 days (±12.9 SD) on average. The mean weight at the first dose was 3388 (SD ± 903) grams. Only 0.6% and 0.2% of infants reported abdominal colic and fever above 38.5 °C in the 14 days after the first dose, respectively. Overall, 1.9% EAEs were observed at 14 days and 0.4% at 28 days after the first/second dose administration. Conclusions: Data obtained from this study confirm the safety of the monovalent rotavirus vaccine even in preterm infants with gestational age ≥ 28 weeks, presenting an opportunity to improve the vaccination offer both in Sicily and in Italy by protecting the most fragile infants who are more at risk of contracting severe rotavirus gastroenteritis and nosocomial RV infection. Full article
(This article belongs to the Special Issue Measure to Improve Vaccination Coverage In at Risk Categories: Pregnant Women, Healthcare Workers and Patients with Chronic Diseases—Second Edition)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop